Metabolic reprogramming of terminally exhausted CD8+ T cells by IL-10 enhances anti-tumor immunity
Yugang Guo(University of Science and Technology of China), Li Tang(École Polytechnique Fédérale de Lausanne), Xin Xie(Soochow University), Weihua Xiao(University of Science and Technology of China), Ping‐Chih Ho(Ludwig Cancer Research), Werner Held(Centre National de la Recherche Scientifique), Alessio Bevilacqua(Ludwig Cancer Research), Mathias Wenes(University of Geneva), Amphun Chaiboonchoe, Bing Feng(Chinese Academy of Sciences), Imran Siddiqui(St. Vincent's Medical Center), Benjamin Tschumi(University of Lausanne), Fabien Franco(Ludwig Cancer Research), Weimin Li(Sichuan University), Yang Zhao(École Polytechnique Fédérale de Lausanne), Yuxi Wang(Second Affiliated Hospital of Dalian Medical University), Hanshuo Yang(Sichuan University), Min Gao(Central South University), Haiping Wang(Shaanxi Normal University), Catherine Sabatel(University of Lausanne), Pedro Romero(TiGenix (Spain)), Yuqing Xie(École Polytechnique Fédérale de Lausanne)
Cited by 422
Related Papers
Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escape
|Science|1996|1.3k
TLR3 Deficiency in Patients with Herpes Simplex Encephalitis
|Science|2007|1.1k
T Cell Factor 1-Expressing Memory-like CD8+ T Cells Sustain the Immune Response to Chronic Viral Infections
|Immunity|2016|1.1k
Estimates and Projections of the Global Economic Cost of 29 Cancers in 204 Countries and Territories From 2020 to 2050
|JAMA Oncology|2023|822
Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery
|Nature Biotechnology|2018|641